You've probably heard the names Ozempic and Wegovy in the news. But when people talk about compounded semaglutide, they're often confused about what it actually means and how it differs from the brand-name drugs dominating headlines.
Let's clear that up completely.
What Is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medication that mimics a hormone your body naturally produces after eating. When you take semaglutide, it signals your brain that you're full, slows gastric emptying, and reduces appetite significantly.
The active ingredient is the same whether you're talking about Ozempic (approved for type 2 diabetes), Wegovy (approved for chronic weight management), or compounded semaglutide. The molecule itself is identical.
What Does "Compounded" Mean?
Compounded medications are prepared by a licensed pharmacy, not manufactured by a pharmaceutical company like Novo Nordisk. They're made to order, typically when:
- A patient needs a dose or formulation that isn't commercially available
- The brand-name product is on an FDA shortage list
- A physician determines that a customized formulation better serves a patient's needs
Compounding pharmacies must comply with strict state and federal regulations. Those operating as 503B outsourcing facilities meet additional FDA standards for quality, sterility, and consistency.
Is Compounded Semaglutide Legal?
Yes, under specific conditions. During an FDA shortage of a drug, compounding pharmacies are permitted to prepare that drug for patient use. Semaglutide has been on the FDA shortage list due to overwhelming demand, which opened the legal pathway for compounded versions.
It's worth noting that compounded medications are not FDA-approved as finished drug products. The FDA approval process applies to specific drug products, not to pharmacies compounding active ingredients. However, the active ingredient (semaglutide) itself is well-studied and the same as what's in Ozempic and Wegovy.
How ZenOryva Uses Compounded Semaglutide
At ZenOryva, every prescription is written by a board-certified provider after a clinical evaluation. We partner exclusively with 503B-licensed compounding pharmacies, which means your medication is:
- Sterile: Prepared in pharmaceutical-grade clean rooms
- Third-party tested: Every batch is tested for potency and purity
- Properly dosed: Titrated to your specific starting point and escalation schedule
Your medication is shipped directly to your door, typically within 5-7 business days of approval.
Dosing and Titration
One of the biggest advantages of compounded semaglutide is dosing flexibility. Most patients start at 0.25 mg per week, administered as a subcutaneous injection. Over 4-8 weeks, doses are gradually increased based on tolerance and response, typically reaching 1 mg or 2.4 mg at maintenance.
Your ZenOryva provider will guide every step of this titration based on how you're responding and any side effects you experience.
What to Expect
Most members notice a meaningful reduction in appetite within the first two weeks. Weight loss typically begins in weeks two through four, and becomes more pronounced by months two and three.
Clinical data shows that patients using semaglutide for weight management lose an average of 15-20% of body weight over 68 weeks when combined with lifestyle support, which is exactly what the ZenOryva platform provides.
The Bottom Line
Compounded semaglutide gives more people access to a clinically proven weight loss intervention at a more accessible price point. When sourced from a reputable 503B pharmacy and prescribed by a qualified provider, it is a safe and effective option for chronic weight management.
If you're ready to find out whether you're a candidate, take the ZenOryva assessment. It takes less than two minutes.